And so it goes on, yet another reason why the 4000%+ higher price of currently used auto-immune and cancer treatments vs Low Dose Naltrexone (LDN) cannot be ignored any longer. The potential billions of pounds in savings here make the millions required for LDN clinical trials a sound investment for the NHS in Scotland and the UK as a whole.
http://bit.ly/SPLDNcost
Saturday, 12 December 2009
UK Telegraph - NICE Propose to Restrict Key IBD Treatments to One Year on Grounds of Cost
Yet more justification, if any were needed that the UK NHS needs to seriously look into widespread use of Low Dose Naltrexone (LDN) as a low cost treatment for Crohn's Disease, Ulcerative Colitis and the any other conditions it has been used successfully to reat including other auto-immune disease, cancers, autism and HIV/AIDs.
At £12,500 per patient per year for Infliximab versus £300 per year for Low Dose Naltrexone, it is the proverbial 'no-brainer' for the NHS to do whatever it takes to convince consultants and GPs that LDN is a suitable drug choice for IBD.
The government and public bodies need to cease dithering on this and take action now so that IBD sufferers need not suffer unnecessarily.
http://bit.ly/NICEIBD
At £12,500 per patient per year for Infliximab versus £300 per year for Low Dose Naltrexone, it is the proverbial 'no-brainer' for the NHS to do whatever it takes to convince consultants and GPs that LDN is a suitable drug choice for IBD.
The government and public bodies need to cease dithering on this and take action now so that IBD sufferers need not suffer unnecessarily.
http://bit.ly/NICEIBD
Tuesday, 8 December 2009
Round-Up of LDN Now Low Dose Naltrexone Campaign at The Scottish Parliament Public Petitions Committee
Original video of the meeting here (Click link 01/12/2009 and fast forward 39 minutes to LDN Now meeting) -
http://bit.ly/SPLDNvid1
youtube version -
http://bit.ly/SPLDNvid
Interview segment from Holyrood TV Highlights programme (Click link 03/12/2009 and fast forward to 16:00 minutes) -
http://bit.ly/SPLDNint
Full transcript of the meeting -
http://bit.ly/SPLDNmin
http://bit.ly/SPLDNvid1
youtube version -
http://bit.ly/SPLDNvid
Interview segment from Holyrood TV Highlights programme (Click link 03/12/2009 and fast forward to 16:00 minutes) -
http://bit.ly/SPLDNint
Full transcript of the meeting -
http://bit.ly/SPLDNmin
Saturday, 5 December 2009
Minute from the LDN Now Scotland Scottish Parliament meeting on Low Dose Naltrexone (LDN) Availability on the NHS in Scotland
The first minute of the meeting is available here - http://bit.ly/SPLDNmin1
Some key quotes (Paraphrased)
Robin Harper, (Scottish Green Party) - Basis for clinical trial exists with current LDN evidence. Suggest GPs gather clinical data on LDN use.
Anne McLaughlin (SNP) - Committee needs to write to charities to ask if they will help fund trials.
Nigel Don (SNP) - LDN is a drug that treats the immune system drug and clinical trials are required for all conditions it can be shown to treat.
John Wilson (SNP) - Health charities should be encouraged to ensure they are spending money on researching all options for their patients, including LDN.
Frank McAveety (Labour) - The issue that the private sector will not fund trials due to no profit motive is clear and is noted.
Some key quotes (Paraphrased)
Robin Harper, (Scottish Green Party) - Basis for clinical trial exists with current LDN evidence. Suggest GPs gather clinical data on LDN use.
Anne McLaughlin (SNP) - Committee needs to write to charities to ask if they will help fund trials.
Nigel Don (SNP) - LDN is a drug that treats the immune system drug and clinical trials are required for all conditions it can be shown to treat.
John Wilson (SNP) - Health charities should be encouraged to ensure they are spending money on researching all options for their patients, including LDN.
Frank McAveety (Labour) - The issue that the private sector will not fund trials due to no profit motive is clear and is noted.
Subscribe to:
Posts (Atom)